Steven S Richards

US Patent:

8404957, Mar 26, 2013

Filed:

Oct 31, 2011

Appl. No.:

13/286042

Inventors:

Steven S. Richards - Snohomish WA, US

International Classification:

G10D 13/02

US Classification:

84413, 84411 R

Abstract:

An acoustic-drum tuning assembly includes a single adjustment feature to vary the drumhead tension uniformly around the drumhead's periphery. The tuning mechanism includes multiple rings located between the end of the drum shell (or support ring) and the “underside” of the drumhead, which is otherwise restrained with respect to the drum shell by a hoop or rim fixed in place by threaded tension rods and lugs or other hoop-fixing mechanism. The single adjustment feature varies the circumference of a wedging ring, which generates an axial force “expanding” or “retracting” the tuning assembly along the central axis of the drum. When the tuning assembly axially “expands”, it pushes increasingly “upward” against the drumhead, variably increasing its tension and the musical pitch of the drum. When the tuning assembly axially “retracts”, it decreases the “upward” push, variably decreasing the drumhead tension and lowering the musical pitch of the drum.

US Patent:

20090247559, Oct 1, 2009

Filed:

Dec 22, 2008

Appl. No.:

12/341210

Inventors:

S. David Brown - San Carlos CA, US
Hongwang Du - Millbrae CA, US
Maurizio Franzini - Redwood City CA, US
Adam Antoni Galan - Alameda CA, US
Ping Huang - Mountain View CA, US
Patrick Kearney - San Francisco CA, US
Moon Hwan Kim - Palo Alto CA, US
Elena S. Koltun - Foster City CA, US
Steven James Richards - San Francisco CA, US
Amy L. Tsuhako - Milpitas CA, US
Cristiana A. Zaharia - Foster City CA, US

Assignee:

Exelixis, Inc. - South San Francisco CA

International Classification:

A61K 31/519
C07D 487/04
A61P 35/00

US Classification:

514267, 544234

Abstract:

A compound according to formula I:or a pharmaceutically acceptable salt thereof; wherein R, R, R, R, Rand Rare as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.

US Patent:

20220257533, Aug 18, 2022

Filed:

Nov 29, 2021

Appl. No.:

17/537260

Inventors:

- South Plainfield NJ, US
Jeffery K. TRIMMER - San Carlos CA, US
William SHRADER - Belmont CA, US
Andrew W. HINMAN - San Francisco CA, US
Charles R. HOLST - San Jose CA, US
Joey C. LATHAM - San Carlos CA, US
Joel J. BRUEGGER - Campbell CA, US
Kevin P. MCCUSKER - Berkeley CA, US
Gözde ULAS - Sunnyvale CA, US
Dana DAVIS - Sunnyvale CA, US
Edgar P. LEE - Mountain View CA, US
Stephanie A. MALONE - San Francisco CA, US
Steven J. RICHARDS - Brisbane CA, US
Matthew B. KLEIN - Menlo Park CA, US

International Classification:

A61K 31/122
A61P 29/00

Abstract:

Compounds, compositions, and methods for treatment of, or prophylaxis against, inflammation and/or oxidative stress are disclosed.

US Patent:

20210238119, Aug 5, 2021

Filed:

Apr 12, 2021

Appl. No.:

17/228648

Inventors:

- South Plainfield NJ, US
Steven J. Richards - Brisbane CA, US

International Classification:

C07C 50/28
A61P 39/06
C07C 50/24
C07D 295/108
C07C 317/04
C07D 207/06
C07D 213/65
C07C 225/24

Abstract:

Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging, or for modulating one or more energy biomarkers, normalizing one or more energy biomarkers, or enhancing one or more energy biomarkers, wherein the compounds are tocopherol quinone derivatives. Further disclosed are compounds, compositions, and methods for treatment of, or prophylaxis against, radiation exposure.

US Patent:

20210002240, Jan 7, 2021

Filed:

Feb 22, 2019

Appl. No.:

16/968836

Inventors:

- Stanford CA, US
Dean W. Felsher - San Mateo CA, US
Feng Jin - Stanford CA, US
Richard N. Zare - Stanford CA, US
Katherine Margulis - San Francisco CA, US
Steven R. Schow - Redwood City CA, US
Robert J. Greenhouse - Newark CA, US
David Loughhead - Belmont CA, US
Steven Richards - Stanford CA, US

International Classification:

C07D 295/092
C07C 311/08
A61P 35/00

Abstract:

Inhibitors of Glycerol 3-Phosphate Acyltransferase (GPAT) are provided; and methods of use in the treatment of cancer; and treatment of conditions relating to metabolic syndrome and hyperlipidemia.

US Patent:

20200403826, Dec 24, 2020

Filed:

Sep 23, 2019

Appl. No.:

16/579743

Inventors:

- Seattle WA, US
Joseph Elmar Magerramov - Bellevue WA, US
Zachary Brandes - Seattle WA, US
Apoorv Mittal - Seattle WA, US
Bharadwaj Avva - Bothell WA, US
Ryan James Schaefer - Seattle WA, US
Kiran Venkat Sayeeram Karpurapu - Seattle WA, US
Ajay Jha - Seattle WA, US
Steven Bruce Richards - Seattle WA, US
Richard H Galliher - Seattle WA, US

International Classification:

H04L 12/46
H04L 12/26

Abstract:

Technologies are disclosed for monitoring network traffic using traffic mirroring. According to some examples, traffic mirroring allows customers to monitor traffic at different sources within a VPC. For example, a source may be any Elastic Network Interface (ENI) in their VPC, including elastic network interfaces (ENIs) on virtual machine instances, Network Address Translation (NAT) Gateways, Load Balancers, VPC endpoints, Internal Gateways, Transit Gateways, and more. Filters can be utilized to determine the network traffic to mirror. A customer may also configure to monitor real-time traffic with a monitoring appliance of their choice. With traffic mirroring, data traffic may be identified and sent to one or more target devices. Customers may monitor traffic within a VPC for content inspection, forensic analysis, troubleshooting, record keeping, and the like. Using traffic mirroring, customers can replicate VPC traffic, along with full payload data, without installing and managing agents on virtual machine instances.

US Patent:

20200331835, Oct 22, 2020

Filed:

Jul 6, 2020

Appl. No.:

16/946786

Inventors:

- SOUTH PLAINFIELD NJ, US
Steven J. RICHARDS - Brisbane CA, US

International Classification:

C07C 50/28
C07C 50/24
C07D 207/06
A61P 39/06
C07C 225/24
C07C 317/04
C07D 213/65
C07D 295/108

Abstract:

Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases of aging, or for modulating one or more energy biomarkers, normalizing one or more energy biomarkers, or enhancing one or more energy biomarkers, wherein the compounds are tocopherol quinone derivatives. Further disclosed are compounds, compositions, and methods for treatment of, or prophylaxis against, radiation exposure.

US Patent:

20200121618, Apr 23, 2020

Filed:

Apr 14, 2018

Appl. No.:

16/605192

Inventors:

- Mountain View CA, US
Jeffery K. TRIMMER - San Carlos CA, US
William D. SHRADER - Belmont CA, US
Andrew W. HINMAN - San Francisco CA, US
Charles R. HOLST - San Jose CA, US
Joey C. LATHAM - San Carlos CA, US
Joel J. BRUEGGER - Campbell CA, US
Kevin P. MCCUSKER - Berkeley CA, US
Gozde ULAS - Sunnyvale CA, US
Dana DAVIS - Sunnyvale CA, US
Edgar P. LEE - Mountain View CA, US
Stephanie A. MALONE - San Francisco CA, US
Steven J. RICHARDS - Brisbane CA, US
Matthew B. KLEIN - Menlo Park CA, US

International Classification:

A61K 31/122
A61P 29/00

Abstract:

Compounds, compositions, and methods for treatment of, or prophylaxis against, inflammation and/or oxidative stress are disclosed.